Bioequivalence studies of reformulated pharmaceuticals newly off patent

1. Chen, ML, Shah V, Patnaik R, Adams W, Hussain A, Conner D, et al. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res. 2001; 18: 1645-50.10.1023/A:1013319408893Open DOISearch in Google Scholar

2. Raw AS, Furness MS, Gill DS, Adams RC, Holcombe FO, Yu LX. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv Drug Deliv Rev. 2004; 56:397-414.10.1016/j.addr.2003.10.01114962589Search in Google Scholar

3. WHO Tech Rep Ser. Additional guidelines for organizations performing in vivo bioequivalence studies. Geneva 2006.Search in Google Scholar

4. Jullangkoon, M, Jarurathanasirikul S, Ainlang N. Bioequivalence study of cefepime intramuscular injection in healthy volunteers. Asian Biomed. 2014; 8: 237-4010.5372/1905-7415.0802.284Search in Google Scholar